Product Information
DOXEPIN 100 MG CAPSULE is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.2901 per EA under NDC 23155079801. Its NADAC has been published 225 times since Jun 15, 2022.
FDA first approved this application on Apr 1, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155079801
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214908FDA Approved
4/1/2021
TE Code
AB
On Market Since
12/30/2021
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN 100 MG CAPSULE has been published 225 times since Jun 15, 2022, and over the history we have for it it has declined 38.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2901 per EA |
|---|---|
| All-time high | $0.6888 (Jul 13, 2022) |
| All-time low | $0.2255 (Feb 19, 2025) |
| 52-week high | $0.2936 |
| 52-week low | $0.2324 |
| Median price | $0.2936 |
| Average price | $0.3343 |
| Largest weekly change | +46.8% (Aug 21, 2024) |
| Weeks tracked | 225 |
| Tracking since | Jun 15, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Doxepn Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Heritage Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Doxepn Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tricyclic Antidepressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXEPIN 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 100 MG CAPSULE, manufactured by Heritage Pharmaceuticals Inc., is $0.2901 per EA (NDC 23155079801), effective Sep 30, 2026.
How has the price of DOXEPIN 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOXEPIN 100 MG CAPSULE has declined 38.6%. It has been tracked across 225 weekly CMS publications since Jun 15, 2022.
What are the highest and lowest recorded NADAC prices for DOXEPIN 100 MG CAPSULE?
Since Jun 15, 2022, the NADAC for DOXEPIN 100 MG CAPSULE has ranged from a low of $0.2255 (Feb 19, 2025) to a high of $0.6888 (Jul 13, 2022), with a median of $0.2936 per EA.
Are there cheaper alternatives to DOXEPIN 100 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of DOXEPIN 100 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DOXEPIN 100 MG CAPSULE?
DOXEPIN 100 MG CAPSULE (NDC 23155079801) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.